Innate Pharma (NasdaqGS:IPHA) 2025 Conference Transcript
Innate Pharma (NasdaqGS:IPHA) 2025 Conference November 17, 2025 09:30 AM ET Company ParticipantsSonia Quaratino - Chief Medical OfficerYannis Morel - COONausica Zunini - Healthcare Investment Banking AssociateStéphanie Cornen - VP of Investor Relations and Commercial Strategy OfficerJonathan Dickinson - CEONausica ZuniniGood afternoon, everybody, and welcome to Jefferies 2025 Global Healthcare Conference. I'm Nausica Zunini from our healthcare investment banking team, and it's my pleasure now to introduce y ...